FR2405298A1 - Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments - Google Patents

Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments

Info

Publication number
FR2405298A1
FR2405298A1 FR7702266A FR7702266A FR2405298A1 FR 2405298 A1 FR2405298 A1 FR 2405298A1 FR 7702266 A FR7702266 A FR 7702266A FR 7702266 A FR7702266 A FR 7702266A FR 2405298 A1 FR2405298 A1 FR 2405298A1
Authority
FR
France
Prior art keywords
preparation
application
escherichia coli
medicines
glycoproteins isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7702266A
Other languages
English (en)
French (fr)
Other versions
FR2405298B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassenne Laboratoires
Original Assignee
Cassenne Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassenne Laboratoires filed Critical Cassenne Laboratoires
Priority to FR7702266A priority Critical patent/FR2405298A1/fr
Publication of FR2405298A1 publication Critical patent/FR2405298A1/fr
Application granted granted Critical
Publication of FR2405298B1 publication Critical patent/FR2405298B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7702266A 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments Granted FR2405298A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7702266A FR2405298A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7702266A FR2405298A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments

Publications (2)

Publication Number Publication Date
FR2405298A1 true FR2405298A1 (fr) 1979-05-04
FR2405298B1 FR2405298B1 (OSRAM) 1982-09-17

Family

ID=9185963

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7702266A Granted FR2405298A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments

Country Status (1)

Country Link
FR (1) FR2405298A1 (OSRAM)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
EP0331821A1 (en) * 1988-02-03 1989-09-13 Kureha Kagaku Kogyo Kabushiki Kaisha Antiviral agent
FR2648351A1 (fr) * 1989-06-20 1990-12-21 Roussel Uclaf Utilisation de complexes glycoproteiques extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau et procede de preparation
WO1993016190A1 (fr) * 1992-02-14 1993-08-19 Laboratoires Om Sa Extrait de macromolecules bacteriennes, procede pour sa preparation et composition pharmaceutique contenant cet extrait

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
EP0089266A1 (fr) * 1982-03-09 1983-09-21 Pierre Fabre S.A. Procédé de préparation de protéoglycanes immunostimulants inducteurs d'interféron, protéoglycanes obtenus et médicament les contenant
EP0331821A1 (en) * 1988-02-03 1989-09-13 Kureha Kagaku Kogyo Kabushiki Kaisha Antiviral agent
FR2648351A1 (fr) * 1989-06-20 1990-12-21 Roussel Uclaf Utilisation de complexes glycoproteiques extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau et procede de preparation
EP0404660A3 (fr) * 1989-06-20 1991-12-04 Roussel-Uclaf Utilisation de complexes glycoprotéines extraits de bactéries gram (-) pour la fabrication d'un médicament facilitant la cicatrisation de la peau et procédé de préparation
WO1993016190A1 (fr) * 1992-02-14 1993-08-19 Laboratoires Om Sa Extrait de macromolecules bacteriennes, procede pour sa preparation et composition pharmaceutique contenant cet extrait
US5424287A (en) * 1992-02-14 1995-06-13 Laboratoires Om Sa Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same

Also Published As

Publication number Publication date
FR2405298B1 (OSRAM) 1982-09-17

Similar Documents

Publication Publication Date Title
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
BE881014A (fr) Procede de preparation d'organopolysiloxanes, et produits ainsi obtenus
ES8802390A1 (es) Un procedimiento para extraer la substancia quimica activa de la planta del aloe a partir de hojas de esta planta
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
PT801649E (pt) Derivados de hidroxilamina uteis para aumentar a producao de proteinas moleculares adventicias e sua preparacao
ATE13286T1 (de) Pharmazeutisch aktive phenylcarbonsaeurederivate.
FR2674524B1 (fr) Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2584727B1 (fr) Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
AUPM534794A0 (en) Modified milk growth factor
FR2505185B1 (fr) Procede de preparation d'un polysulfate de chondroitine injectable, produit obtenu par ce procede et compositions pharmaceutiques le contenant
BE884189A (fr) Nouveaux aryl-1 arylsulfonyl-4 gamma-aminopropoxy-3, 1h-pyrazoles, medicament en contenant et procede pour les preparer
FR2378855A1 (fr) Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments
FR2448535A1 (fr) Nouveaux derives tricycliques et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2407262A1 (fr) Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
FR2405298A1 (fr) Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
FR2651227B1 (fr) Nouveaux derives de l'aminopropanol, procede pour leur preparation et compositions pharmaceutiques contenant de tels derives.
BE904846A (fr) Steroides 11beta-substitues utiles notamment dans le traitement des tumeurs hormono-dependantes et procede pour la fabrication.
FR2328692A1 (fr) Procede pour la preparation d'alpha, omega-diamines aliphatiques, et produits obtenus
FR2323391A1 (fr) Procede de production de derives de 1,5-dihydro-2h-1,4-benzodiazepin-2-one, nouveaux produits ainsi obtenus et leur utilisation pharmaceutique, notamment comme produits sedatifs et hypnotiques
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
FR2696179B1 (fr) Derives de thioalkylthiocarbacephalosporine, procede pour leurs preparations et formulation pharmaceutique les contenant pour le traitement ou la prophylaxie des infections bacteriennes.
FI872459A0 (fi) Farmaceutisk produkt foer vaord av bakterie-infektioner.
BE874037A (fr) Procede de preparation d'inhibiteurs d'amylase, nouveaux produits ainsi obtenus et leurs utilisations pharmaceutiques, notamment pour combattre l'obesite et l'hyperglycemie

Legal Events

Date Code Title Description
ST Notification of lapse